Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Webstercountycitizen

Published November 16, 2026 · Updated November 17, 2026

Amidst Missouri legality battle, psychedelics show promise as PPD treatment | News

Read the full story at Webstercountycitizen

psychedelics is restricted to adults with specific, approved diagnoses. Currently, New Mexico is one of 11 U.S. states that have passed psychedelic.

Surfaced by 2 Google Alerts

  • Psychedelics south america
  • Psychedelics europe